SG Americas Securities’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,574
Closed -$132K 2536
2024
Q1
$132K Sell
7,574
-2,588
-25% -$45.1K ﹤0.01% 2071
2023
Q4
$96K Sell
10,162
-8,384
-45% -$79.2K ﹤0.01% 2541
2023
Q3
$207K Sell
18,546
-41,089
-69% -$459K ﹤0.01% 2100
2023
Q2
$1.28M Buy
59,635
+17,222
+41% +$368K 0.01% 863
2023
Q1
$1.72M Buy
42,413
+23,165
+120% +$937K 0.02% 688
2022
Q4
$895K Buy
19,248
+10,815
+128% +$503K 0.01% 919
2022
Q3
$437K Sell
8,433
-16,435
-66% -$852K 0.01% 1466
2022
Q2
$1.18M Sell
24,868
-2,153
-8% -$102K 0.01% 1016
2022
Q1
$1.92M Buy
27,021
+24,153
+842% +$1.72M 0.01% 813
2021
Q4
$214K Sell
2,868
-50,131
-95% -$3.74M ﹤0.01% 2383
2021
Q3
$3.01M Buy
52,999
+7,225
+16% +$410K 0.01% 826
2021
Q2
$2.02M Sell
45,774
-3,152
-6% -$139K 0.01% 1018
2021
Q1
$2.41M Buy
48,926
+3,263
+7% +$161K 0.01% 828
2020
Q4
$1.92M Buy
45,663
+9,491
+26% +$399K 0.01% 977
2020
Q3
$1.66M Buy
36,172
+23,113
+177% +$1.06M 0.01% 698
2020
Q2
$656K Buy
13,059
+8,675
+198% +$436K 0.01% 1551
2020
Q1
$225K Sell
4,384
-2,113
-33% -$108K ﹤0.01% 2027
2019
Q4
$401K Sell
6,497
-10,529
-62% -$650K ﹤0.01% 1686
2019
Q3
$1.02M Buy
17,026
+15,697
+1,181% +$943K 0.01% 1220
2019
Q2
$112K Sell
1,329
-624
-32% -$52.6K ﹤0.01% 2358
2019
Q1
$187K Sell
1,953
-4,956
-72% -$475K ﹤0.01% 2290
2018
Q4
$489K Buy
+6,909
New +$489K ﹤0.01% 1607
2018
Q3
Sell
-1,795
Closed -$208K 2660
2018
Q2
$208K Buy
1,795
+405
+29% +$46.9K ﹤0.01% 2252
2018
Q1
$112K Buy
+1,390
New +$112K ﹤0.01% 2439
2017
Q4
Sell
-5,662
Closed -$265K 2654
2017
Q3
$265K Buy
5,662
+1,308
+30% +$61.2K ﹤0.01% 2045
2017
Q2
$157K Buy
4,354
+237
+6% +$8.55K ﹤0.01% 2269
2017
Q1
$127K Sell
4,117
-3,841
-48% -$118K ﹤0.01% 2486
2016
Q4
$267K Buy
+7,958
New +$267K ﹤0.01% 1889
2015
Q2
Sell
-3,379
Closed -$103K 2142
2015
Q1
$103K Buy
3,379
+1,195
+55% +$36.4K ﹤0.01% 1967
2014
Q4
$111K Buy
+2,184
New +$111K ﹤0.01% 2543